欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/0422/002
药品名称Lipoplus
活性成分
    • omega-3-acid triglycerides 20.0 mg/ml
    • soy-bean oil, refined 80.0 mg/ml
    • triglycerides, medium-chain 100.0 mg/ml
剂型Emulsion for infusion
上市许可持有人B. Braun Melsungen AG Germany
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Germany (DE)
      Lipoplus 20 mg Emulsion zur Infusion
    • Denmark (DK)
      Lipidem
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Lipidem Emulsion zur Infusion
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Norway (NO)
    • Finland (FI)
    • Slovakia (SK)
      Lipoplus 20%
    • Czechia (CZ)
      Lipoplus 20%
    • Poland (PL)
      Lipidem
许可日期2004/10/05
最近更新日期2023/11/20
药物ATC编码
    • B05BA02 fat emulsions
申请类型
  • TypeLevel1：New Active Substance
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Full Dossier Article 4.8 Di 65/65
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase